This poses a significant risk, as unregulated peptides may be contaminated, improperly dosed, or ineffective
These compounded medications have the same active ingredient as the name-brand drugs, but they might include other ingredients like vitamins, so they dont violate pharma patents
Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial (September 2017) Doi: Lisdexamfetamine Dimesylate (Vyvanse), A Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder (May 2010) Doi: The Influence of Depressive Symptoms on Executive Functioning in Binge Eating Disorder: A Comparison of Patients and Non-Obese Healthy Controls (April 2019) Doi: Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review (August 05, 2021) Doi: SSRI Antidepressant Medications: Adverse Effects and Tolerability (February 01, 2001) Doi: Treatment of Obese Patients With Binge Eating Disorder Using Topiramate: A Review (July 07, 2009) Doi: Successful Treatment of Binge Eating Disorder With the GLP-1 Agonist Semaglutide: A Retrospective Cohort Study (August 08, 2023) Doi:
Select Bacteriostatic Water: Always use sterile bacteriostatic water for reconstitution to ensure the longest possible shelf life for your reconstituted solution
The primary patent for Ozempic (semaglutide) is set to expire in December 2031 , with additional protective patents lasting until 2033
Track your progress Your journey, in your pocket Track your journey Log every dose and watch your progress build
